Additionally, CAR-NK cells have the inherent ability to recognize and target tumor cells through activating receptors such as NKG2D, NKp46, and DNAM-1, as well as the capability to kill cancer cells through CD16-mediated ADCC. Here, NCR1 is linked to neoplasm.